Mark I.R. Petalcorin
- Molecular Biology top 5%
- Oncology top 5%
- Physiology top 5%
- Aging top 0.5%
- Cancer Research top 10%
- Co-authors
- Simon J. BoultonJean‐Baptiste VannierHao DingJulie S. MartinAlan D. D’AndreaRavindra AmunugamaTimur YusufzaiRaphaël Ceccaldi
- Topics
- DNA Repair Mechanisms (14 papers)Genetics, Aging, and Longevity in Model Organisms (9 papers)CRISPR and Genetic Engineering (8 papers)
- Cited by
- AgingMolecular BiologyOncology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark I.R. Petalcorin
20 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Molecular Biology 2.1k
- Oncology 556
- Physiology 368
- Aging 278
- Cancer Research 276
Countries citing papers authored by Mark I.R. Petalcorin
This map shows the geographic impact of Mark I.R. Petalcorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark I.R. Petalcorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark I.R. Petalcorin more than expected).
Fields of papers citing papers by Mark I.R. Petalcorin
This network shows the impact of papers produced by Mark I.R. Petalcorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark I.R. Petalcorin. The network helps show where Mark I.R. Petalcorin may publish in the future.
Co-authorship network of co-authors of Mark I.R. Petalcorin
This figure shows the co-authorship network connecting the top 25 collaborators of Mark I.R. Petalcorin. A scholar is included among the top collaborators of Mark I.R. Petalcorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark I.R. Petalcorin. Mark I.R. Petalcorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 5 | |
| 3 | 61 | |
| 4 | 11 | |
| 5 | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repairbreakdown → | 648 |
| 6 | 18 | |
| 7 | 30 | |
| 8 | 58 | |
| 9 | 170 | |
| 10 | 366 | |
| 11 | 183 | |
| 12 | 76 | |
| 13 | 298 | |
| 14 | 52 | |
| 15 | 63 | |
| 16 | 125 | |
| 17 | 54 | |
| 18 | 137 | |
| 19 | 26 | |
| 20 | 27 |
About Mark I.R. Petalcorin
Mark I.R. Petalcorin is a scholar working on Aging, Molecular Biology and Physiology, having authored 20 papers that have together received 2.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (14 papers), Genetics, Aging, and Longevity in Model Organisms (9 papers) and CRISPR and Genetic Engineering (8 papers). The work is most often cited by research in Aging (278 citations), Molecular Biology (2.1k citations) and Oncology (556 citations). Mark I.R. Petalcorin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Simon J. Boulton, Jean‐Baptiste Vannier, Hao Ding, Julie S. Martin, Alan D. D’Andrea, Ravindra Amunugama, Timur Yusufzai, Raphaël Ceccaldi, Panagiotis A. Konstantinopoulos and Stephen J. Elledge. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.